VASOPRESSIN-RESISTANT DIABETES-INSIPIDUS ASSOCIATED WITH SHORT-TERM DEMETHYLCHLORTETRACYCLINE (DECLOMYCIN) THERAPY

被引:0
|
作者
MAXON, HR [1 ]
RUTSKY, EA [1 ]
机构
[1] USN HOSP,DEPT MED,PORTSMOUTH,VA 23708
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:500 / 501
页数:2
相关论文
共 50 条
  • [31] MUTATIONS IN THE V2 VASOPRESSIN RECEPTOR GENE ARE ASSOCIATED WITH X-LINKED NEPHROGENIC DIABETES-INSIPIDUS
    PAN, Y
    METZENBERG, A
    DAS, S
    JING, B
    GITSCHIER, J
    NATURE GENETICS, 1992, 2 (02) : 103 - 106
  • [32] PERSISTENT NEPHROGENIC DIABETES-INSIPIDUS ASSOCIATED WITH LONG-TERM LITHIUM-CARBONATE TREATMENT
    RABIN, EZ
    GARSTON, RG
    WEIR, RV
    POSEN, GA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1979, 121 (02) : 194 - &
  • [33] POINT MUTATIONS IN THE VASOPRESSIN TYPE-2 RECEPTOR GENE (AVPR2) ARE ASSOCIATED WITH NEPHROGENIC DIABETES-INSIPIDUS
    KNOERS, N
    DREESEN, J
    VERDIJK, M
    MONNENS, LAH
    VANDEROUWELAND, A
    VONOOST, BA
    KIDNEY INTERNATIONAL, 1993, 43 (04) : 971 - 971
  • [34] EFFECTS OF INDOMETHACIN ON FLUID INTAKE, URINE VOLUME, URINARY PROSTAGLANDIN E-LIKE MATERIAL AND KALLIKREIN IN VASOPRESSIN RESISTANT DIABETES-INSIPIDUS
    WOHLTMANN, HJ
    HALUSHKA, PV
    PRIVITERA, PJ
    MARGOLIUS, HS
    WAGNER, RG
    PEDIATRIC RESEARCH, 1977, 11 (04) : 433 - 433
  • [35] A NULL MUTATION IN THE VASOPRESSIN-V2 RECEPTOR GENE (AVPR2) ASSOCIATED WITH NEPHROGENIC DIABETES-INSIPIDUS IN THE HOPEWELL KINDRED
    HOLTZMAN, EJ
    KOLAKOWSKI, LF
    OBRIEN, D
    CRAWFORD, JD
    AUSIELLO, DA
    HUMAN MOLECULAR GENETICS, 1993, 2 (08) : 1201 - 1204
  • [36] Silent thyroiditis associated with short-term lithium therapy
    Numata, S
    Taniguchi, K
    Harada, T
    Tomotake, M
    Ohmori, T
    GENERAL HOSPITAL PSYCHIATRY, 2002, 24 (06) : 451 - 453
  • [37] Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus
    Pivonello, R
    Faggiano, A
    Di Somma, C
    Klain, M
    Filippella, M
    Salvatore, M
    Lombardi, G
    Colao, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (07): : 2349 - 2352
  • [38] PLATELET ARGININE-VASOPRESSIN (PLATAVP) - A MARKER OF THE LONG-TERM STIMULATION OF AVP - APPLICATION TO THE RAPID DIAGNOSIS OF CENTRAL VS NEPHROGENIC DIABETES-INSIPIDUS
    ARTHUS, MF
    BICHET, D
    LONERGAN, M
    RAZI, M
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 180 - 180
  • [39] PLATELET ARGININE-VASOPRESSIN (PLATAVP) - A MARKER OF THE LONG-TERM STIMULATION OF AVP - APPLICATION TO THE RAPID DIAGNOSIS OF CENTRAL VS NEPHROGENIC DIABETES-INSIPIDUS
    BICHET, D
    PAPUKNA, V
    RAZI, M
    KORTAS, C
    CLINICAL AND INVESTIGATIVE MEDICINE, 1987, 10 (04): : B107 - B107
  • [40] The response to short-term intensive insulin therapy in type 2 diabetes
    Retnakaran, R.
    Yakubovich, N.
    Qi, Y.
    Opsteen, C.
    Zinman, B.
    DIABETES OBESITY & METABOLISM, 2010, 12 (01): : 65 - 71